Fibroblast was acquired by Cerner Corporation in October 2020. Fibroblast automates the referral process by empowering providers with an easy to use, end-to-end referral tool. By closing the referral loop, Fibroblasts prevents patient leakage, increasing revenues for fee-for-service organizations and lowering risks for accountable care organizations. Fibroblast delivers a clear, compelling return on investment.
View Top Employees from Fibroblast (Acquired by Cerner Corporation)Website | http://www.fibroblast.com |
Revenue | $6 million |
Funding | $2.9 million |
Employees | 2 (1 on RocketReach) |
Founded | 2010 |
Address | 640 N La Salle St, Chicago, Illinois 60654, US |
Phone | (800) 396-6463 |
Industry | IT Services and IT Consulting, Hospitals & Clinics, Enterprise Software, Healthcare, Software, Health Care, Information Technology, Medical |
Web Rank | 6 Million |
Keywords | @Par8o.Com, Fibroblast Par8o |
Competitors | Evariant Patient Solutions (CRM), Jellyfish Health, Kyruus, MyHealthDirect, a part of Experian, Treatspace |
SIC | SIC Code 80 Companies, SIC Code 809 Companies |
NAICS | NAICS Code 621 Companies, NAICS Code 6219 Companies, NAICS Code 62199 Companies, NAICS Code 62 Companies |
Looking for a particular Fibroblast (Acquired by Cerner Corporation) employee's phone or email?
The Fibroblast (Acquired by Cerner Corporation) annual revenue was $6 million in 2024.
1 people are employed at Fibroblast (Acquired by Cerner Corporation).
Fibroblast (Acquired by Cerner Corporation) is based in Chicago, Illinois.
The NAICS codes for Fibroblast (Acquired by Cerner Corporation) are [621, 6219, 62199, 62].
The SIC codes for Fibroblast (Acquired by Cerner Corporation) are [80, 809].